BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17624467)

  • 1. Need for liver evaluation in polycystic ovary syndrome.
    Carmina E
    J Hepatol; 2007 Sep; 47(3):313-5. PubMed ID: 17624467
    [No Abstract]   [Full Text] [Related]  

  • 2. [Polycystic ovarian syndrome incidence in young women with non-alcoholic fatty liver disease].
    Ciotta L; Pagano I; Stracquadanio M; Formuso C
    Minerva Ginecol; 2011 Oct; 63(5):429-37. PubMed ID: 21926952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sonographic measurement of mesenteric fat predicts presence of fatty liver among subjects with polycystic ovary syndrome.
    Ma RC; Liu KH; Lam PM; Cheung LP; Tam WH; Ko GT; Chan MH; Ho CS; Lam CW; Chu WC; Tong PC; So WY; Chan JC; Chow CC
    J Clin Endocrinol Metab; 2011 Mar; 96(3):799-807. PubMed ID: 21190980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of abnormal liver enzymes and metabolic syndrome in obese adolescent females with polycystic ovary syndrome.
    Barfield E; Liu YH; Kessler M; Pawelczak M; David R; Shah B
    J Pediatr Adolesc Gynecol; 2009 Oct; 22(5):318-22. PubMed ID: 19576817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome.
    Setji TL; Holland ND; Sanders LL; Pereira KC; Diehl AM; Brown AJ
    J Clin Endocrinol Metab; 2006 May; 91(5):1741-7. PubMed ID: 16492691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical update on screening, diagnosis and management of metabolic disorders and cardiovascular risk factors associated with polycystic ovary syndrome.
    Huang G; Coviello A
    Curr Opin Endocrinol Diabetes Obes; 2012 Dec; 19(6):512-9. PubMed ID: 23108199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic ovary syndrome - an update.
    Boyle J; Teede HJ
    Aust Fam Physician; 2012 Oct; 41(10):752-6. PubMed ID: 23210095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptotic markers indicate nonalcoholic steatohepatitis in polycystic ovary syndrome.
    Tan S; Bechmann LP; Benson S; Dietz T; Eichner S; Hahn S; Janssen OE; Lahner H; Gerken G; Mann K; Canbay A
    J Clin Endocrinol Metab; 2010 Jan; 95(1):343-8. PubMed ID: 19906783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.
    Gambarin-Gelwan M; Kinkhabwala SV; Schiano TD; Bodian C; Yeh HC; Futterweit W
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):496-501. PubMed ID: 17287148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and laboratory diagnosis of the metabolic syndrome.
    Olufadi R; Byrne CD
    J Clin Pathol; 2008 Jun; 61(6):697-706. PubMed ID: 18505888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polycystic ovary syndrome and comorbidity].
    Haugaard LK; Vestergaard H; Skouby SO
    Ugeskr Laeger; 2010 Jan; 172(3):199-202. PubMed ID: 20089210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polycystic ovarian syndrome is a health risk].
    Hippeläinen M
    Duodecim; 2002; 118(10):981-3. PubMed ID: 12238006
    [No Abstract]   [Full Text] [Related]  

  • 13. Polycystic ovary syndrome.
    Braillon A
    N Engl J Med; 2005 Jun; 352(26):2756-7; author reply 2756-7. PubMed ID: 15987930
    [No Abstract]   [Full Text] [Related]  

  • 14. Report of the international symposium: polycystic ovary syndrome: first Latin-American consensus.
    Motta AB
    Int J Clin Pract; 2010 Apr; 64(5):544-57. PubMed ID: 20456209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty liver index in polycystic ovary syndrome.
    Lerchbaum E; Gruber HJ; Schwetz V; Giuliani A; Möller R; Pieber TR; Obermayer-Pietsch B
    Eur J Endocrinol; 2011 Dec; 165(6):935-43. PubMed ID: 21937505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress in women: metabolic syndrome and polycystic ovary syndrome.
    Diamanti-Kandarakis E; Economou F
    Ann N Y Acad Sci; 2006 Nov; 1083():54-62. PubMed ID: 17148733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased prevalence of gestational diabetes mellitus among women with diagnosed polycystic ovary syndrome: a population-based study.
    Lo JC; Feigenbaum SL; Escobar GJ; Yang J; Crites YM; Ferrara A
    Diabetes Care; 2006 Aug; 29(8):1915-7. PubMed ID: 16873802
    [No Abstract]   [Full Text] [Related]  

  • 18. Adolescent polycystic ovary syndrome.
    Connor EL
    Adolesc Med State Art Rev; 2012 Apr; 23(1):164-77, xii. PubMed ID: 22764561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory hepatocellular adenomatosis, metabolic syndrome, polycystic ovary syndrome and non-alcoholic steatohepatitis: chance tetrad or association by necessity?
    Nascimbeni F; Ballestri S; Di Tommaso L; Piccoli M; Lonardo A
    Dig Liver Dis; 2014 Mar; 46(3):288-9. PubMed ID: 24183950
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnosis, phenotype, and prevalence of polycystic ovary syndrome.
    Carmina E; Azziz R
    Fertil Steril; 2006 Jul; 86 Suppl 1():S7-8. PubMed ID: 16798288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.